Information:
Fel:
ID
39918
Beskrivning
Nebivolol in Patients With Systolic Stage 2 Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01057251
Länk
https://clinicaltrials.gov/show/NCT01057251
Nyckelord
Versioner (1)
- 2020-03-04 2020-03-04 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
4 mars 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hypertension NCT01057251
Eligibility Hypertension NCT01057251
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01057251
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
male of female, 18 to 64 years of age at screening
boolean
C0001779 (UMLS CUI [1])
Heart rate while sitting mean
Item
mean seated heart rate at least 60 bpm
boolean
C2029904 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C0444504 (UMLS CUI [1,2])
Systolic hypertension Stage
Item
diagnosed systolic stage 2 hypertension
boolean
C0221155 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C0699749 (UMLS CUI [1,2])
Findings Normal Physical Examination
Item
unremarkable physical exam findings
boolean
C0037088 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0205307 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
High risk | Secondary hypertension | Hypertensive disease Previous Stage
Item
high risk due to secondary hypertension or former stage 3 hypertension by jnc6
boolean
C4319571 (UMLS CUI [1])
C0155616 (UMLS CUI [2])
C0020538 (UMLS CUI [3,1])
C0205156 (UMLS CUI [3,2])
C0699749 (UMLS CUI [3,3])
C0155616 (UMLS CUI [2])
C0020538 (UMLS CUI [3,1])
C0205156 (UMLS CUI [3,2])
C0699749 (UMLS CUI [3,3])
Comorbidity | Kidney Diseases | Cardiovascular Diseases | Obesity | Thyroid Diseases
Item
concurrent conditions (reno, cardiovascular, obesity, thyroid, etc)
boolean
C0009488 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0028754 (UMLS CUI [4])
C0040128 (UMLS CUI [5])
C0022658 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0028754 (UMLS CUI [4])
C0040128 (UMLS CUI [5])
Pharmaceutical Preparation Discontinue Unsuccessful
Item
currently taking medication that cannot be stopped during the course of the study
boolean
C0013227 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
C1444662 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
Study Subject Participation Status | Clinical Trial
Item
participating other clinical trials
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [2])
Member Research Personnel
Item
member of the study center personnel
boolean
C0680022 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0035173 (UMLS CUI [1,2])
Drug abuse
Item
documented drug abuse
boolean
C0013146 (UMLS CUI [1])
Medical contraindication Adrenergic beta-1 Receptor Antagonists
Item
contra indication to beta blocker
boolean
C1301624 (UMLS CUI [1,1])
C0304516 (UMLS CUI [1,2])
C0304516 (UMLS CUI [1,2])
Laboratory test result abnormal
Item
abnormal lab finding
boolean
C0438215 (UMLS CUI [1])
Poor compliance
Item
poor compliance
boolean
C0032646 (UMLS CUI [1])
Condition Inappropriate Clinical Trial
Item
other conditions judged by investigator that is not suitable for the study
boolean
C0348080 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])